WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 47'6401 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 45'6161 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 80'689  80'646  80'566  80'478  80'425  81'896  78'958  78'160 
Births 685  680  674  670  666  748  827  812 
Surviving infants 683  678  672  668  664  745  821  801 
Pop. less than 5 years 3'384  3'364  3'346  3'334  3'330  3'892  4'335  3'957 
Pop. less than 15 years 10'397  10'466  10'549  10'647  10'756  12'597  12'575  14'551 
Female 15-49 years 17'303  17'543  17'763  17'963  18'153  19'597  19'376  19'159 

Number of reported cases

(Click for retrospective incidence data for Germany)
Diphtheria
ChartChart
  14  19 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  2'464  443  1'771  166  1'607  28'745 
Mumps
ChartChart
  699  837 
Pertussis
ChartChart
  9'000  12'260  258 
Polio*
ChartChart
 
Rubella
ChartChart
  90  151 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  18  21 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Germany)
Vaccine year result method % card seen                                                
BCG         
DTP1          99  99  99 
DTP3          96  96  96  78  80 
DTP4          96  96 
IPV1          99  99 
HepB_BD         
HepB3          88  88  87  86  87  45 
Hib3          94  94  94  94  93  82 
JapEnc         
MCV1          97  97  97  97  96  92  50 
MCV2          93  93  92  92  92 
PCV1          88 
PCV3          85  85  68  41  15 
Pol3          95  95  95  95  94  95  85 
Rota1         
RotaC         
Rubella1          97  96  96  96  96 
TT2plus          80 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Germany)
DTP1
ChartChart
  98  98  98  98  95  93 
DTP3
ChartChart
  96  96  96  96  90  80 
HepB3
ChartChart
  87  87  87  87  84 
HepB_BD
ChartChart
 
Hib3
ChartChart
  94  94  94  94  94 
MCV1
ChartChart
  97  97  97  97  92  75  25 
MCV2
ChartChart
  92  92  92  92 
PCV3
ChartChart
  68  68  68  68 
Pol3
ChartChart
  95  95  95  95  94  80  80 
RotaC
ChartChart
 

Number of districts in the country 402  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaP 2, 3, 4, 11-14 months; Yes
DTaPHibHepIPV 2, 3, 4, 11-14 months; Yes
DTaPHibIPV 2, 3, 4, 11-14 months; Yes
HPV 9-14 years x2; Yes females - cathch up for Y14-Y17 (x3 doses)
HepB_Pediatric 2, 4, 11-14 months; Yes
Influenza_Adult > 60 years; Yes elderly, pregnant women, helath care workers, adults with chronic disease and other risk groups
Influenza_Pediatric Yes children with chronic disease
MMR 11-14, 15-23 months; Yes And adults born after 1970
MMRV 15-23 months; Yes
MenC_conj 11-23 months; Yes
Pneumo_conj 2, 4, 11-14 months; Yes
Pneumo_ps >=60 years; Yes
Rotavirus 6, 10, 14 weeks; Yes 3rd dose depending on vaccine presentation
TBE > 2 years; No population in defined high risk regions
TdaPIPV 9-17 years; Yes
Tdap 5-6 years; Yes every 10 years
Varicella 11-14, 15-23 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 402  402  402  412  412  423  424 
Nº districts with DTP3 coverage >=80% number              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   NA  NA  NA  NA     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.